{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:46:18Z","timestamp":1790520378585,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jaci.2020.12.654","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T11:45:54Z","timestamp":1612957554000},"page":"563-573.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["PD-L1 on mast cells suppresses effector CD8+ T-cell activation in the skin in murine contact hypersensitivity"],"prefix":"10.1016","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1399-1686","authenticated-orcid":false,"given":"Tomoko","family":"Hirano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuto","family":"Kanameishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyohei","family":"Egawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Kitoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeko","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruki","family":"Dainichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Yaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Inozume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki R.","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Tamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kabashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2020.12.654_bib1","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2020.12.654_bib2","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the Pd-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2020.12.654_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-017-0329-9","article-title":"Cancer immunotherapies targeting the PD-1 signaling pathway","volume":"24","author":"Iwai","year":"2017","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.jaci.2020.12.654_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1084\/jem.20022235","article-title":"PD-1 inhibits antiviral immunity at the effector phase in the liver","volume":"198","author":"Iwai","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2020.12.654_bib5","doi-asserted-by":"crossref","first-page":"12293","DOI":"10.1073\/pnas.192461099","article-title":"Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade","volume":"99","author":"Iwai","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2020.12.654_bib6","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jaci.2020.12.654_bib7","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.12.654_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2018.00086","article-title":"Anti-PD-1 and anti-CTLA-4 therapies in cancer: Mechanisms of action, efficacy, and limitations","volume":"8","author":"Seidel","year":"2018","journal-title":"Front. Oncol"},{"key":"10.1016\/j.jaci.2020.12.654_bib9","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jaci.2020.12.654_bib10","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1172\/JCI96061","article-title":"PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression","volume":"128","author":"Tang","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2020.12.654_bib11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/jid.2012.284","article-title":"Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis","volume":"133","author":"Honda","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.12.654_bib12","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/ni.2992","article-title":"Perivascular leukocyte clusters are essential for efficient activation of effector T cells in the skin","volume":"15","author":"Natsuaki","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2020.12.654_bib13","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1038\/jid.2008.174","article-title":"Impaired initiation of contact hypersensitivity by FTY720","volume":"128","author":"Nakashima","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.12.654_bib14","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/ni1503","article-title":"Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B","volume":"8","author":"Grimbaldeston","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2020.12.654_bib15","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.immuni.2011.03.028","article-title":"Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens","volume":"34","author":"Dudeck","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2020.12.654_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123947","article-title":"Cutaneous immune responses mediated by dendritic cells and mast cells","volume":"4","author":"Sumpter","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2020.12.654_bib17","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1038\/sj.jid.5700819","article-title":"Activation of the IL-1\u03b2-processing inflammasome is involved in contact hypersensitivity","volume":"127","author":"Watanabe","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.12.654_bib18","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1038\/jid.2008.5","article-title":"Cutaneous hypersensitivities to hapten are controlled by IFN-\u03b3-upregulated keratinocyte Th1 chemokines and IFN-\u03b3- downregulated langerhans cell Th2 chemokines","volume":"128","author":"Mori","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.12.654_bib19","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1189\/jlb.0805436","article-title":"High-level expression of B7-H1 molecules by dendritic cells suppresses the function of activated T cells and desensitizes allergen-primed animals","volume":"79","author":"Kim","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2020.12.654_bib20","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.4049\/jimmunol.0902478","article-title":"Keratinocyte-associated B7-H1 directly regulates cutaneous effector CD8+ T cell responses","volume":"184","author":"Ritprajak","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2020.12.654_bib21","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.jaci.2018.11.048","article-title":"Inhibitory checkpoint receptors control CD8+ resident memory T cells to prevent skin allergy","volume":"143","author":"Gamradt","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.12.654_bib22","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1002\/eji.200324084","article-title":"Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses","volume":"33","author":"Tsushima","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2020.12.654_bib23","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1111\/all.13853","article-title":"Immune microenvironment controls the outcome of PD-1 blockade in cutaneous immune response","volume":"74","author":"Ogawa","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.12.654_bib24","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/70932","article-title":"B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion","volume":"5","author":"Dong","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2020.12.654_bib25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1074-7613(04)00050-0","article-title":"B7-H1 determines accumulation and deletion of intrahepatic CD8+ T lymphocytes","volume":"20","author":"Dong","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2020.12.654_bib26","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jaci.2010.12.1101","article-title":"Characterization of a novel human mast cell line that responds to stem cell factor and expresses functional Fc\u03b5RI","volume":"127","author":"Laidlaw","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.12.654_bib27","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.immuni.2009.08.022","article-title":"Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions","volume":"31","author":"Stelekati","year":"2009","journal-title":"immunity"},{"key":"10.1016\/j.jaci.2020.12.654_bib28","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.4049\/jimmunol.0803180","article-title":"Inducible MHC class II expression by mast cells supports effector and regulatory T cell activation","volume":"182","author":"Kambayashi","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2020.12.654_bib29","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1084\/jem.20160783","article-title":"Mast cells acquire MHCII from dendritic cells during skin inflammation","volume":"214","author":"Dudeck","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2020.12.654_bib30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaci.2017.05.029","article-title":"Human mast cells as antigen-presenting cells: when is this role important in\u00a0vivo?","volume":"141","author":"Galli","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.12.654_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/database\/baw105","article-title":"FANTOM5 transcriptome catalog of cellular states based on Semantic MediaWiki","volume":"2016","author":"Abugessaisa","year":"2016","journal-title":"Database (Oxford)"},{"key":"10.1016\/j.jaci.2020.12.654_bib32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13059-014-0560-6","article-title":"Gateways to the FANTOM5 promoter level mammalian expression atlas","volume":"16","author":"Lizio","year":"2015","journal-title":"Genome Biol"},{"key":"10.1016\/j.jaci.2020.12.654_bib33","doi-asserted-by":"crossref","first-page":"D752","DOI":"10.1093\/nar\/gky1099","article-title":"Update of the FANTOM web resource: expansion to provide additional transcriptome atlases","volume":"47","author":"Lizio","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaci.2020.12.654_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2013-02-483792","article-title":"Redefinition of the human mast cell transcriptome by deep-CAGE sequencing","volume":"123","author":"Motakis","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.12.654_bib35","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0145-2126(02)00343-0","article-title":"Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma\/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI","volume":"27","author":"Kirshenbaum","year":"2003","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2020.12.654_bib36","first-page":"123","article-title":"Cutaneous Toxicities of immune checkpoint inhibitors: the role of the dermatologist","volume":"93","author":"Tattersall","year":"2020","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.jaci.2020.12.654_bib37","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1158\/1078-0432.CCR-15-2872","article-title":"Cytotoxic cutaneous adverse drug reactions during anti-PD-1 therapy","volume":"22","author":"Goldinger","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaci.2020.12.654_bib38","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejca.2016.02.025","article-title":"Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy","volume":"60","author":"Hofmann","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaci.2020.12.654_bib39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jdcr.2017.09.028","article-title":"Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma","volume":"4","author":"Griffin","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaci.2020.12.654_bib40","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ejca.2017.03.026","article-title":"Pembrolizumab-induced Stevens-Johnson syndrome in non-melanoma patients","volume":"81","author":"Saw","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaci.2020.12.654_bib41","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.clindermatol.2019.10.015","article-title":"The life-threatening eruptions of immune checkpoint inhibitor therapy","volume":"38","author":"Coleman","year":"2020","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaci.2020.12.654_bib42","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jaad.2018.10.062","article-title":"Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A\u00a0single-institution retrospective analysis with stratification of reactions by toxicity and implications for management","volume":"80","author":"Coleman","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.12.654_bib43","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1684\/ejd.2019.3522","article-title":"DIHS\/DRESS-like eruption possibly induced by amoxicillin during treatment with nivolumab","volume":"29","author":"Takimoto","year":"2019","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaci.2020.12.654_bib44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1074-7613(00)80089-8","article-title":"Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor","volume":"11","author":"Nishimura","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2020.12.654_bib45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.it.2006.02.001","article-title":"The PD-1-PD-L pathway in immunological tolerance","volume":"27","author":"Okazaki","year":"2006","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2020.12.654_bib46","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.4049\/jimmunol.176.4.2238","article-title":"Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF","volume":"176","author":"Nakae","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2020.12.654_bib47","article-title":"Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata","volume":"9","author":"Keren","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2020.12.654_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-019-0530-3","article-title":"Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-\u03b1-PD-L1 pathway","volume":"7","author":"Lv","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jaci.2020.12.654_bib49","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/exd.12716","article-title":"Proposal of inducible skin-associated lymphoid tissue (iSALT)","volume":"24","author":"Ono","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2020.12.654_bib50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41577-018-0084-5","article-title":"The immunological anatomy of the skin","volume":"19","author":"Kabashima","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2020.12.654_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.06.005","article-title":"Programmed cell death 1 (PD-1) regulates the effector function of CD8 T cells via PD-L1 expressed on target keratinocytes","volume":"53","author":"Okiyama","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaci.2020.12.654_bib52","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1084\/jem.20150381","article-title":"Resolvin E1 inhibits dendritic cell migration in the skin and\u00a0attenuates\u00a0contact hypersensitivity responses","volume":"212","author":"Sawada","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2020.12.654_bib53","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0145-2126(02)00343-0","article-title":"Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma\/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI","volume":"27","author":"Kirshenbaum","year":"2003","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2020.12.654_bib54","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jaci.2010.12.1101","article-title":"Characterization of a novel human mast cell line that responds to stem cell\u00a0factor\u00a0and expresses functional Fc\u03b5RI","volume":"127","author":"Laidlaw","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.12.654_bib55","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1182\/blood-2009-03-211714","article-title":"Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.12.654_bib56","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/cmi.2017.106","article-title":"Human\u00a0PBMC-transferred murine MHC class I\/II-deficient NOG mice enable long-term evaluation of human immune responses","volume":"15","author":"Yaguchi","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jaci.2020.12.654_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/database\/baw105","article-title":"FANTOM5 transcriptome catalog of cellular states based on Semantic MediaWiki","volume":"2016","author":"Abugessaisa","year":"2016","journal-title":"Database (Oxford)"},{"key":"10.1016\/j.jaci.2020.12.654_bib58","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13059-014-0560-6","article-title":"Gateways to the FANTOM5 promoter level mammalian expression atlas","volume":"16","author":"Lizio","year":"2015","journal-title":"Genome Biol"},{"key":"10.1016\/j.jaci.2020.12.654_bib59","doi-asserted-by":"crossref","first-page":"D752","DOI":"10.1093\/nar\/gky1099","article-title":"Update of the FANTOM web resource: expansion to provide additional transcriptome atlases","volume":"47","author":"Lizio","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaci.2020.12.654_bib60","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2013-02-483792","article-title":"Redefinition of the human mast cell transcriptome by deep-CAGE sequencing","volume":"123","author":"Motakis","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.12.654_bib61","series-title":"EnhancedVolcano: publication-ready volcano plots with enhanced colouring and labeling. R package, version 1.6.0","author":"Blighe","year":"2020"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921001780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921001780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:30:59Z","timestamp":1758792659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674921001780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0091674921001780"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2020.12.654","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739548623.793584349","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PD-L1 on mast cells suppresses effector CD8+ T-cell activation in the skin in murine contact hypersensitivity","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2020.12.654","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}